ECCOGENE 诚益生物
Slogan: Pursue extraordinary innovation for a healthier life
Description: Eccogene is a biopharmaceutical company founded in 2018 with a dedication to providing innovative therapeutic solutions for unmet medical needs globally. The company's focus lies in the discovery and development of translational medicine for metabolic and immune-related diseases. Eccogene's expertise in disease biology, medicinal chemistry, and translational science drives the advancement of its novel and differentiated pipeline of drugs.
Industries: Health Care
Headquarter: China
Last Investment: CNY180.00M Series B investment at 12 June 2023
Last Investment Investors: New Alliance Capital, Qingsong Fund, Delos Capital, Acusea/Huiyuan Capital, Yufu Capital, Elikon Venture, Shanghai Zhangjiang Haocheng Venture Capital, Oriza Seed Capital (Oriza Yuandian)
No recent news or press coverage available for Eccogene.